Fingerprint
Dive into the research topics of 'Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
Elizabeth J. Rowe, Tyler Shugg, Reynold C. Ly, Santosh Philips, Marc B. Rosenman, John T. Callaghan, Milan Radovich, Brian R. Overholser, Bryan P. Schneider, James E. Tisdale, Todd C. Skaar*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review